Skip to content
Review Open access

Supportive organ management in acute right ventricular failure secondary to pulmonary embolism: a narrative review

Sep 2026 · Journal of Education, Health and Sport · 0 citations · 27 references

TL;DR

The pathophysiology of ARVF in PE and available supportive strategies are reviewed, appraising their efficacy, safety and evidence quality, and management of ARVF in PE demands combined causal and supportive treatment.

Abstract

Background. Pulmonary embolism (PE) is among the most common cardiovascular syndromes and a leading cause of acute right ventricular failure (ARVF), which drives haemodynamic and respiratory deterioration and high mortality. While causal treatment removes the thrombus, supportive organ management keeps patients alive until it takes effect, yet clear algorithms are lacking. Aim. To review the pathophysiology of ARVF in PE and available supportive (haemodynamic, oxygenation, ventilation) strategies, appraising their efficacy, safety and evidence quality. Material and methods. Narrative review of PubMed and Google Scholar (2016–2026, with justified exceptions), using Boolean combinations of terms on right ventricular failure, PE and organ support. 36 studies were narratively synthesised, each assessed for design, sample size and methodology. Results. ARVF in PE stems from RV pressure overload uncoupling contractility from afterload, causing RV dilatation, septal shift, LV underfilling and ischaemia. Supportive care targets preload, afterload and contractility. High-flow oxygen therapy appears superior to low-flow and possibly comparable to non-invasive ventilation; positive-pressure ventilation risks haemodynamic harm. Fluids require cautious titration guided by CVP and VExUS. Noradrenaline and dobutamine are preferred; levosimendan and milrinone reduce pulmonary vascular resistance but risk hypotension. Inhaled vasodilators (notably nitric oxide) and oxygen show promise but unproven benefit. Mechanical circulatory support (mainly VA-ECMO) is a bridging option, best combined with embolectomy. Conclusions. Management of ARVF in PE demands combined causal and supportive treatment, but much supportive care rests on extrapolated or low-quality evidence; PE-specific studies are needed.

Read PDF

Similar papers

Review Open access Sep 2026

Multimodal Management of Chronic Thromboembolic Pulmonary Hypertension: A Narrative Review of Treatment Selection and Sequencing

A narrative review synthesises evidence published through January 2026 and emphasises that, because each modality carries distinct indications and risks, decisions should be individualised through multidisciplinary assessment at expert centres, with early referral central to optimising outcomes.

H. Gharsalli, M. Alshahrani, O. Harbi et al. · 0 citations
Review Open access Sep 2026

An integrated overview of acute heart failure: a narrative review of pathophysiological mechanisms and contributing factors

Acute heart failure (AHF) is a significant cardiovascular syndrome characterized by either new-onset heart failure (HF) or acutely decompensated heart failure (ADHF), typically presenting with systemic and pulmonary congestion. The European Society of Cardiology has reinforced the importance of early guideline-directed...

Mohammadjavad Sotoudeheian, Mohammad Moradi, Mohammad Pirhayati et al. · 0 citations
Review Open access Sep 2026

CARDIOGENIC SHOCK: CONTEMPORARY MANAGEMENT, RISK STRATIFICATION AND PHENOTYPING

Background. Cardiogenic shock (CS) is a highly lethal clinical syndrome characterised by inadequate cardiac output and end-organ hypoperfusion. Despite advances in contemporary management, mortality remains unacceptably high. The aetiological spectrum of CS is broadening beyond acute myocardial infarction, and manageme...

Przemysław Rajzer, Wiktor Szczuciński, Krzysztof Drelich et al. · 0 citations
Review Open access Sep 2026

Acute Pulmonary Embolism: Current Concepts in Risk Stratification and Management

Current evidence on the pathophysiology, diagnosis, risk stratification, and management of acute PE is summarized, incorporating recommendations from the 2019 European Society Of Cardiology/European Respiratory Society guideline, the 2026 AHA/ACC/Multisociety guideline, the 2024 NAMS (India) Task Force report, and rece...

Atithi Arora, Y. Gupta, Rosmy Jose et al. · 0 citations
Review Open access Aug 2026

Role of ECMO and percutaneous mechanical thrombectomy in the management of acute pulmonary embolism

The evolving paradigm positions VA-ECMO combined with percutaneous pulmonary mechanical thrombectomy as the preferred combination for the high-risk PE patients (acute right ventricular failure, refractory shock, and cardiac arrest), while percutaneous pulmonary mechanical thrombectomy alone with standby VA-ECMO suffice...

M. Davies, Joseph P. Hart · 0 citations
Open access Sep 2026

Right ventricular dysfunction in cardiogenic shock on temporary mechanical circulatory support

Abstract Aims Right ventricular dysfunction (RVD) is common in cardiogenic shock (CS) due to left ventricular failure and is associated with increased mortality, but its impact in patients requiring temporary mechanical circulatory support (tMCS) remains unclear. We explored RVD and its association with clinical outcom...

J. Estoppey, Iulia-Maia Muresan, Matthias Bossard et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.